Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines | NCT00856414 | Trialant
CompletedInterventionalPhase 4Updated Jan 29, 2019
Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines
ClinicalTrials.gov ID
NCT00856414
Lead Sponsor
AllerganINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 4
Enrollment
45Actual
Last Update Posted
Jan 29, 2019Actual
Start Date
Mar 2009
Primary Completion Date
Apr 2009Actual
Completion Date
Apr 2009Actual
Brief Summary
This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)
Skin Aging
botulinum toxin Type A
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Female subjects of any race, 35-55 years of age
Moderate to severe glabellar wrinkles (lines between the eyebrows)
Exclusion Criteria:
Previous botulinum toxin therapy
Subjects who are pregnant, breast-feeding, or who are of childbearing potential and not practicing a reliable method of birth control
Subjects planning a facial cosmetic procedure or visible scars
Previous cosmetic surgery to the upper face
Medical condition that may increase their risk of exposure to botulinum toxin including diagnosed Myasthenia Gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis, or any other disease that might interfere with neuromuscular function
History of facial nerve palsy
Allergy or sensitivity to any component of the study medication